Impact

Key Highlights

• Members of the PlasmaPLUS project contribute to the EU COST action PlasaTHER
• PlasmaPLUS research was presented orally at the 3^rd PlasTHER meeting in Budapest, Hungary, June 10^th – 13^th
• The research was presented by poster at the 10^th International Conference on Plasma Medicine (ICPM10) in Slovenia on the 8^th-13^th Sept 2024 (winning the second poster prize).
• PlasmaPLUS research was further disseminated to the wider public through outreach activities at the National Ploughing Championships, Sept 2024.

Selected publications

1. Byrne K, Bednarz N, McEvoy C, Stephens JC, Curtin JF, Kinsella GK. Development of Novel Anticancer Pyrazolopyrimidinones Targeting Glioblastoma. ChemMedChem. 2025 Oct 15;20(20):e202500337. doi: 10.1002/cmdc.202500337. Epub 2025 Aug 8. PMID: 40626906; PMCID: PMC12530846.
2. He, Z., Charleton, C., Devine, R. W., et al., Enhanced pyrazolopyrimidinones cytotoxicity against glioblastoma cells activated by ROS-Generating cold atmospheric plasma, European Journal of Medicinal Chemistry, 2021, 224, 113736. doi.org/10.1016/j.ejmech.2021.113736